Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BDSIW

Biodelivery Sciences International (MM) (BDSIW)

Biodelivery Sciences International (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BDSIW
DateTimeSourceHeadlineSymbolCompany
09/11/200501:44Business WireBDSI Announces Supply Agreement Relating to BEMA(TM) Fentanyl; Agreement with Aveva Drug Delivery Systems a Key Milestone as BDSNASDAQ:BDSIWBiodelivery Sciences International (MM)
01/11/200523:30Business WireBDSI Prepares For Phase III with BEMA(TM) Fentanyl Following Positive Results of Comparative Pharmacokinetic StudyNASDAQ:BDSIWBiodelivery Sciences International (MM)
06/10/200501:13Business WireBDSI Closes Public Offering of 4.4 Million SharesNASDAQ:BDSIWBiodelivery Sciences International (MM)
30/09/200522:04Business WireBDSI Prices Public Offering of 4.4 Million SharesNASDAQ:BDSIWBiodelivery Sciences International (MM)
30/09/200522:00Business WireBDSI Prices Public Offering of 4.4 Million SharesNASDAQ:BDSIWBiodelivery Sciences International (MM)
17/09/200506:30Business WireBDSI Announces Director Resignations; Donald Ferguson and Alan Pearce Resign So That Company Can Comply with Nasdaq IndependenceNASDAQ:BDSIWBiodelivery Sciences International (MM)
21/07/200500:28Business WireBDSI Announces Acceptance of Emezine(R) NDA for Review By FDANASDAQ:BDSIWBiodelivery Sciences International (MM)
19/07/200501:03Business WireBDSI Secures $7 Million Financing Commitment For Development of BEMA(TM) Fentanyl; Funding Targeted for Phase III Trials of CancNASDAQ:BDSIWBiodelivery Sciences International (MM)
03/06/200521:00Business WireBDSI Secures Additional $2.5 Million Financing With Laurus Master FundNASDAQ:BDSIWBiodelivery Sciences International (MM)
02/05/200521:30Business WireBDSI Announces Submission of NDA for Emezine; First Transmucosal Product for the Treatment of Nausea and VomitingNASDAQ:BDSIWBiodelivery Sciences International (MM)
13/11/200408:37PR Newswire (US)BDSI Reports Financial Results for the Third Quarter Ended September 30, 2004NASDAQ:BDSIWBiodelivery Sciences International (MM)
14/04/200402:00PR Newswire (US)BioDelivery Sciences International, Inc. Announces Licensing of Its Topical BioNasal (TM) Amphotericin B for Chronic SinusitisNASDAQ:BDSIW
06/04/200422:00PR Newswire (US)BioDelivery Sciences International, Inc. Reports 2003 ResultsNASDAQ:BDSIWBiodelivery Sciences International (MM)
 Showing the most relevant articles for your search:NASDAQ:BDSIW